Grade My Investments
HomeFree Stock Grades › AVTR

Avantor, Inc. (AVTR) Stock Grade

AVTR · Healthcare

C
Grade updated: August 16, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$9.2B
P/E Ratio
Revenue Growth (YoY)
-3.4%
Net Margin
-8.1%
Return on Equity
Dividend Yield
None

About Avantor, Inc.'s fundamentals

Avantor is a $9.2 billion healthcare company that supplies medical instruments and related products, though it is currently unprofitable with a net margin of -8.1% based on its latest annual results. The company is facing headwinds with revenue declining 3.4% year-over-year, which reflects softening demand in its markets. Despite accounting losses, Avantor maintains positive free cash flow, suggesting the underlying business generates cash despite its reported net loss. The company does not pay a dividend.

Track AVTR free — no credit card required. Live grade + monthly AI report →